Jubilant Ingrevia Limited Bombay S.E.

Equities

JUBLINGREA

INE0BY001018

Specialty Chemicals

Market Closed - Bombay S.E. 06:23:39 2024-04-25 am EDT 5-day change 1st Jan Change
560.2 INR +0.96% Intraday chart for Jubilant Ingrevia Limited +4.05% +10.40%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Jubilant Ingrevia Issues Commercial Papers Worth INR1 Billion MT
Jubilant Ingrevia Limited Commissions New Facility for Diketenes & Derivatives CI
Jubilant Ingrevia Fully Redeems INR500 Million Commercial Paper at Maturity MT
Jubilant Ingrevia, O2 Renewable Tie Up for Green Energy Generation; Shares Drop 4% MT
Jubilant Ingrevia Commissions Multi-Purpose Agro Active and Intermediate Plant in Gujarat, India MT
Transcript : Jubilant Ingrevia Limited, Q3 2024 Earnings Call, Jan 30, 2024
Jubilant Ingrevia Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Jubilant Ingrevia Limited Approves Interim Dividend for the Financial Year 2023-24, Payable on or Before February 28, 2024 CI
Jubilant Ingrevia Limited Commissions Mutipurpose Agro Intermediate Plant for Value Added Derivatives CI
Jubilant Ingrevia Redeems INR1 Billion Commercial Paper at Maturity MT
Jubilant Ingrevia Redeems INR1 Billion at Maturity Date MT
Jubilant Ingrevia Raises INR1 Billion from Commercial Papers MT
Transcript : Jubilant Ingrevia Limited, Q2 2024 Earnings Call, Nov 01, 2023
Jubilant Ingrevia Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Jubilant Ingrevia Limited Announces Change in Management CI
Jubilant Ingrevia Raises INR1 Billion from Commercial Paper Issue MT
Jubilant Ingrevia Raises INR2 Billion Via Issue of Commerical Papers MT
Jubilant Ingrevia Names Managing Director-CEO MT
Jubilant Ingrevia Limited Approves Final Dividend for the Financial Year Ended March 31, 2023 CI
Jubilant Ingrevia Limited Approves Appointment of Deepak Jain as CEO, Effective October 1, 2023 CI
Jubilant Ingrevia Limited Approves Appointment of Deepak Jain as Director and Managing Director, Effective October 1, 2023 CI
Jubilant Ingrevia Gets Board Nod to Raise Up To INR6 Billion Via Issue of Commercial Paper MT
Transcript : Jubilant Ingrevia Limited, Q1 2024 Earnings Call, Jul 27, 2023
Jubilant Ingrevia Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Jubilant Ingrevia Raises INR1.25 Billion Via Issue of Commercial Papers MT
Chart Jubilant Ingrevia Limited
More charts
Jubilant Ingrevia Limited is an India-based integrated provider of life sciences products and solutions. The Company's segments include Speciality Chemicals, Nutrition and Health Solutions, and Chemical Intermediates. The Speciality Chemicals segment includes pyridine and picolines, fine chemicals, agro chemicals, and custom development and manufacturing organization. The Nutrition and Health Solutions segment includes nutrition and health ingredients, and animal and human nutrition health solutions. The Chemical Intermediates segment includes acetyls and speciality ethanol. Its agro chemicals business is focused on agro intermediates and agro actives, including insecticides, herbicides and fungicides. Its range of products includes nutritional ingredients, such as vitamin B3, vitamin B4, picolinates and premix formulations for both animal and human nutrition. The Company serves various industries, such as pharmaceutical, nutrition, agrochemical, consumer and industrial customers.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
560.2 INR
Average target price
557.3 INR
Spread / Average Target
-0.50%
Consensus
  1. Stock Market
  2. Equities
  3. JUBLINGREA Stock
  4. JUBLINGREA Stock
  5. News Jubilant Ingrevia Limited
  6. Jubilant Ingrevia : to Acquire 26.6% Stake in Solar Power Company AMP Energy